Completed NA INTERVENTIONAL NCT00214695

A Subjective Evaluation of Inflow Pain Associated With the Use of an Experimental Solution for Peritoneal Dialysis

Sponsor: Baxter Healthcare Corporation

Interventions Experimental Peritoneal Dialysis Solution

Updated 7 times since 2017 Last updated: Feb 24, 2025 Started: May 31, 2005 Completion: Jul 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates End Stage Renal Disease and is currently completed. Baxter Healthcare Corporation leads this study, which shows 7 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Apr 2025 — Present [monthly]

Completed NA
Mar 2025 — Apr 2025 [monthly]

Completed NA
Sep 2024 — Mar 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

May 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baxter Healthcare Corporation
Vantive Health LLC

Data source: Vantive Health LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Huddinge, Sweden